What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

Similar documents
LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Pathology of Hematopoietic and Lymphoid tissue

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Pathology of Hematopoietic and Lymphoid tissue

Lymphoma and Myeloma Kris3ne Kra4s, M.D.

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

WHAT ARE PAEDIATRIC CANCERS

HAEMATOLOGICAL MALIGNANCY

1 Introduction. 1.1 Cancer. Introduction

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification

Lymphatic System Disorders

CLL & SLL: Current Management & Treatment. Dr. Isabelle Bence-Bruckler

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

If unqualified, Complete remission is considered to be Haematological complete remission

Diseases Of The Blood

Disorders of Blood Cells & Blood Coagulation

If unqualified, Complete remission is considered to be Haematological complete remission

Lymphoma 101. Nathalie Johnson, MDPhD. Division of Hematology Jewish General Hospital Associate Professor of Medicine, McGill University

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

Treatment results in ALL

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Adult Acute leukemia. Matthew Seftel. August

Leukemia and Myelodysplastic Syndromes

Recommended Timing for Transplant Consultation

Hematologic Malignancies. Kim Noonan, RN, ANP, AOCN

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

CELL-MEDIATED IMMUNITY

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

Pediatric Oncology. Vlad Radulescu, MD

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Hematologic Malignancies. Eunice S. Wang MD Leukemia Service, Department of Medicine Roswell Park Cancer Institute SUNY-UB School of Medicine

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

CLL & SLL: Current Management & Treatment. Dr. Peter Anglin

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Blood Cancer: Chronic Myelogenous Leukaemia

Case Workshop of Society for Hematopathology and European Association for Haematopathology

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

MS.4/ 1.Nov/2015. Acute Leukemia: AML. Abdallah Abbadi

HEMATOLOGIC MALIGNANCIES BIOLOGY

Jeanne Palmer February 26, 2017 Mayo Clinic, Phoenix, AZ

Leukemia. There are different types of leukemia and several treatment options for each type.

Heme 9 Myeloid neoplasms

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

New Evidence reports on presentations given at EHA/ICML Bendamustine in the Treatment of Lymphoproliferative Disorders

5/21/2018. Disclosures. Objectives. Normal blood cells production. Bone marrow failure syndromes. Story of DNA

N Engl J Med Volume 373(12): September 17, 2015

Charles Mxxx DCEM2 Toulouse Purpan Medical School 01/26/2012 ECN Item 162

CLL: disease specific biology and current treatment. Dr. Nathalie Johnson

Acute myeloid leukemia. M. Kaźmierczak 2016

What s a Transplant? What s not?

Acute Lymphoblastic Leukaemia

بسم هللا الرحمن الرحيم

Relapsed acute lymphoblastic leukemia. Lymphoma Tumor Board. July 21, 2017

The AML subtypes are based on how mature (developed) the cancer cells are at the time of diagnosis and how different they are from normal cells.

Flow Cytometry. Leukemia and Myelodysplastic Syndromes. Bone Marrow Aspirate and Biopsy

Non-Hodgkin lymphoma

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Flow Cytometry. Bone Marrow Aspirate and Biopsy. Leukemia and Myelodysplastic Syndromes

NON HODGKINS LYMPHOMA: AGGRESSIVE Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

Mantle Cell Lymphoma

BLOOD AND LYMPH CANCERS

Hodgkin's Lymphoma. Symptoms. Types

2013 Pathology Student

BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

PET-adapted therapies in the management of younger patients (age 60) with classical Hodgkin lymphoma

Lancashire and South Cumbria Haematology NSSG Guidelines for Follicular Lymphoma:

Leukemia and Myelodysplastic Syndromes

Indolent Lymphomas. Dr. Melissa Toupin The Ottawa Hospital

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

Lymphomas and multiple myeloma 12/23/2018 1

Lymphoma is a cancer that develops in the white blood cells (lymphocytes) of the lymphatic system, which is part of the body's immune system.

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Aggressive NHL and Hodgkin Lymphoma. Dr. Carolyn Faught November 10, 2017

Hematology Unit Lab 2 Review Material

Easy Trick to Spot Leukemia for Pediatricians

Early diagnosis saves lives #SpotLeukaemia

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

Recent diagnostic and therapeutic innovations of T-cell-lymphoma. Prof. Nossrat Firusian, Recklinghausen, Germany

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Highlights from the 2017 Annual Meeting of the American Society of Hematology

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)

Indolent Lymphomas: Current. Dr. Laurie Sehn

MANTLE CELL LYMPHOMA

Haematological malignancy in pregnancy

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand

Hematopathology Case Study


Transcription:

Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements in the blood. The malignancies may be classified into Lymphomas Hodgekins versus non-hodgekins leukemias Chronic versus acute Etiology of hematological malignancies 1. Host Factors a. Hereditary b. Chromosomal abnormalities c. Immunodeficiency Leukemias Divided as Acute or chronic Myeloid or lymphoid 2. Environmental Factors a. Ionizing radiation b. Chemicals c. Drugs d. Viruses Lymphocytic and myelocytic The lymphocytic leukemias are caused by cancerous production of lymphoid cells myelogenous leukemia, begins by cancerous production of young myelogenous cells-precaucers of WBC other than lymphocytes 1

Acute vs Chronic Leukemias Chronic in which the onset is gradual,the disease is less aggressive, and the cells involved are usually more mature cells. Acute in which the onset is usually rapid, the disease is very aggressive, and the cells involved are usually poorly differentiated with many BLASTS Clinically, acute leukemia is defined as a disease in which the patient die within 6 months without treatment. ALL acute lymphocytic leukemia CLL chronic lymphocytic leukemia AML-acute myeloid leukemia CML-chronic myeloid leukemia Acute vs Chronic Leukemia Acute vs Chronic Age Acute All ages Chronic Usually adults Acute Leukemia= Blasts in marrow and often blood. Clinical Onset Course (untreated) Leukemic cells sudden 6 mo Blasts insidious 2-6 yrs More mature cells Chronic Leukemia= mature appearing cells in marrow and blood. WBC count Variable High Acute leukemia Rapid progression of symptoms Uncontrolled proliferation of blast cells in bone narrow results in bone marrow failure Blast cells infiltrate organs causing problems Bone Marrow Failure Leukopenia : Infections, sepsis Anemia: Fatigue, Pallor Thrombocytopenia: Bleeding 2

Furthermore, Infiltration of tissues/organs causes: Gum Hypertrophy Enlargement of liver, spleen, lymph nodes Gum hypertrophy Bone pain Other organs: CNS, skin, testis, any organ Pictures Of Blood Platelet Platelet White Cell Red Cell Red Cell White Cell Blasts Symptoms Anemia Infections Hepatosplenomegaly Fever Night sweats Enlarged lymph nodes Normal human blood Sources from Arginine.umdnj.edu Blood with leukemia Sources from beyond2000.com 3

CLL CML Treatment of chronic leukemias Chronic lymphocytic leukemia: rituximab, steroids, fludarabine, bendamustine, ibrutinib. ALL Lymphoblasts Chronic myeloid leukemia: Tyrosine kinase inhibitors eg gleevec. Polycythemia vera: phlebotomy and hydroxyurea. Treatment of acute leukemias Induction chemotherapy: clear bone marrow of all leukemia. Consolidation chemotherapy to keep the disease from coming back. If the risk of relapse is very high, then one would consider an allo transplant as consolidation. Treatment of Acute Myeloid Leukemia Typical induction chemotherapy is Idarubicin (or Daunorubicin) daily x 3 days and cytarabine by civi x 7 days (7+3). Check cardiac function before anthracycline chemotherapy. Cyatarabine can be associated with cerebellar and ocular toxicity but not typically at this dose. 4

Consolidation chemo for AML Consolidation often consists of high dose of cytarabine q 12 hrs x6. Pts needs cerebellar checks prior to each chemo dose and steroid eye drops because of risk of conjunctivitis. Treatment of acute lymphoblastic lymphoma Induction chemotherapy is more complex than AML. Use multiple drug combinations. All patients with ALL need CNS prophylaxis eg IT methotrexate and/or IT cytarabine. Presentation of lymphomas Painless lymphadenopathy Enlarged liver and spleen Recurrent fever and infections Night sweats weight loss Leukemia vs Lymphoma Leukemia= increased WBC in blood and marrow Lymphoma usually starts in secondary lymphoid tissues, especially lymph nodes, so usually the patient is presented to the physician with lymphoadenopathy Lymphomas Could be classified as: - Hodgkin s Lymphoma - Non-Hodgkin s Lymphoma 5

Hodgkin s Lymphoma It is characterized by: - B cell in origin, and the presence of: Reed-Sternberg Cell REED-STERNBERG CELLS Non-Hodgink s Lymphoma The term is used to characterize all other lymphomas in which the description of Hodgkin s lymphoma is not applied, i.e. whenever there is NO REED-Sternberg cells, it could be due to B or T or NK cells involvement. Comparison of Hodgkin Lymphoma and Non-Hodgkin Lymphoma Feature Hodgkin Lymphoma Non-Hodgkin Lymphoma Nodal involvement Spread Localized to a specific group of nodes Tends to spread in an orderly, contiguous fashion Usually disseminated among > 1 no group Spreads noncontiguous Extranodal involvement Infrequent Frequent Stage at diagnosis Usually early Usually advan Histologic classification in children Usually one with a favorable prognosis Usually high grade PET Scan PET scan in a patient with HD Before treatment 6

After treatment Treatment of lymphoma Hodgkins disease: ABVD or BEACOPP. Diffuse large B cell lymphoma: R-CHOP. Relapsed lymphoma: R-ICE or R-DiHAP. Multiple Myeloma 7

Presentation of multiple myeloma Acute renal failure. Proteinuria. Anemia. Bone pain. Pathological fractures. Hypercalcemia. Monoclonal protein in the blood or the urine. Febrile Neutropenia Medical Emergency Neutropenia defined as ANC <0.5. Temp >100.5 deg F (oral). Panculture: blood, urine, sputum, etc. CXR. Start on abs asap. Gram negative coverage is imperative (eg cefepime). Gram positive coverage if patients have a central line (eg vancomycin). 8